BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 19821367)

  • 1. Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures.
    Koch MW; Polman SK
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006453. PubMed ID: 19821367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxcarbazepine versus phenytoin monotherapy for epilepsy.
    Muller M; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003615. PubMed ID: 16625587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Jul; (7):CD001904. PubMed ID: 26204241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001911. PubMed ID: 28240353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Aug; (8):CD001911. PubMed ID: 26275105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD001904. PubMed ID: 27976799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Tudur Smith C; Weston J; Marson AG
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD001031. PubMed ID: 27841445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxcarbazepine versus phenytoin monotherapy for epilepsy.
    Nolan SJ; Muller M; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2013 May; (5):CD003615. PubMed ID: 23728645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001904. PubMed ID: 30353945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003615. PubMed ID: 30350354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Sudell M; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012065. PubMed ID: 31233229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Sudell M; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD012065. PubMed ID: 27922722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Tudur Smith C; Weston J; Marson AG
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001031. PubMed ID: 29952431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxcarbazepine add-on for drug-resistant partial epilepsy.
    Castillo S; Schmidt DB; White S
    Cochrane Database Syst Rev; 2000; (3):CD002028. PubMed ID: 10908522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Marson AG
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007124. PubMed ID: 20091617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine versus phenobarbitone monotherapy for epilepsy.
    Tudur Smith C; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2003; (1):CD001904. PubMed ID: 12535420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Marson AG
    Cochrane Database Syst Rev; 2014 Feb; (2):CD007124. PubMed ID: 24488654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WITHDRAWN: Oxcarbazepine add-on for drug-resistant partial epilepsy.
    Castillo SM; Schmidt DB; White S; Shukralla A
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD002028. PubMed ID: 27845825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.
    Beydoun A; Sachdeo RC; Rosenfeld WE; Krauss GL; Sessler N; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2000 Jun; 54(12):2245-51. PubMed ID: 10881247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.